Literature DB >> 7568220

X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.

H Brandstetter1, M Bauer, R Huber, P Lollar, W Bode.   

Abstract

Hereditary deficiency of factor IXa (fIXa), a key enzyme in blood coagulation, causes hemophilia B, a severe X chromosome-linked bleeding disorder afflicting 1 in 30,000 males; clinical studies have identified nearly 500 deleterious variants. The x-ray structure of porcine fIXa described here shows the atomic origins of the disease, while the spatial distribution of mutation sites suggests a structural model for factor X activation by phospholipid-bound fIXa and cofactor VIIIa. The 3.0-A-resolution diffraction data clearly show the structures of the serine proteinase module and the two preceding epidermal growth factor (EGF)-like modules; the N-terminal Gla module is partially disordered. The catalytic module, with covalent inhibitor D-Phe-1I-Pro-2I-Arg-3I chloromethyl ketone, most closely resembles fXa but differs significantly at several positions. Particularly noteworthy is the strained conformation of Glu-388, a residue strictly conserved in known fIXa sequences but conserved as Gly among other trypsin-like serine proteinases. Flexibility apparent in electron density together with modeling studies suggests that this may cause incomplete active site formation, even after zymogen, and hence the low catalytic activity of fIXa. The principal axes of the oblong EGF-like domains define an angle of 110 degrees, stabilized by a strictly conserved and fIX-specific interdomain salt bridge. The disorder of the Gla module, whose hydrophobic helix is apparent in electron density, can be attributed to the absence of calcium in the crystals; we have modeled the Gla module in its calcium form by using prothrombin fragment 1. The arched module arrangement agrees with fluorescence energy transfer experiments. Most hemophilic mutation sites of surface fIX residues occur on the concave surface of the bent molecule and suggest a plausible model for the membrane-bound ternary fIXa-FVIIIa-fX complex structure: fIXa and an equivalently arranged fX arch across an underlying fVIIIa subdomain from opposite sides; the stabilizing fVIIIa interactions force the catalytic modules together, completing fIXa active site formation and catalytic enhancement.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568220      PMCID: PMC40889          DOI: 10.1073/pnas.92.21.9796

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Nucleotide sequence of the gene for human factor IX (antihemophilic factor B).

Authors:  S Yoshitake; B G Schach; D C Foster; E W Davie; K Kurachi
Journal:  Biochemistry       Date:  1985-07-02       Impact factor: 3.162

2.  Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketone.

Authors:  P Lollar; D N Fass
Journal:  Arch Biochem Biophys       Date:  1984-09       Impact factor: 4.013

3.  The role of phospholipid and factor VIIIa in the activation of bovine factor X.

Authors:  G van Dieijen; G Tans; J Rosing; H C Hemker
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

4.  Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid.

Authors:  P Lollar; G J Knutson; D N Fass
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

5.  Intrinsic pathway activation of factor X and its activation peptide-deficient derivative, factor Xdes-143-191.

Authors:  E J Duffy; P Lollar
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

6.  The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. II. The binding of the pancreatic trypsin inhibitor and of isoleucine-valine and of sequentially related peptides to trypsinogen and to p-guanidinobenzoate-trypsinogen.

Authors:  W Bode
Journal:  J Mol Biol       Date:  1979-02-05       Impact factor: 5.469

7.  Isolation and characterization of a cDNA coding for human factor IX.

Authors:  K Kurachi; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.

Authors:  B J McRae; K Kurachi; R L Heimark; K Fujikawa; E W Davie; J C Powers
Journal:  Biochemistry       Date:  1981-12-08       Impact factor: 3.162

9.  Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.

Authors:  M J Castillo; K Kurachi; N Nishino; I Ohkubo; J C Powers
Journal:  Biochemistry       Date:  1983-03-01       Impact factor: 3.162

10.  A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.

Authors:  S P Bajaj; S I Rapaport; S L Maki
Journal:  J Biol Chem       Date:  1985-09-25       Impact factor: 5.157

View more
  49 in total

1.  Structure of human factor VIIa and its implications for the triggering of blood coagulation.

Authors:  A C Pike; A M Brzozowski; S M Roberts; O H Olsen; E Persson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity.

Authors:  J A Kolkman; P J Lenting; K Mertens
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

3.  Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.

Authors:  J Y Chang; D M Monroe; D W Stafford; K M Brinkhous; H R Roberts
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

4.  Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.

Authors:  Divi Venkateswarlu
Journal:  Biochem Biophys Res Commun       Date:  2014-08-23       Impact factor: 3.575

5.  Structural basis for chemical inhibition of human blood coagulation factor Xa.

Authors:  K Kamata; H Kawamoto; T Honma; T Iwama; S H Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

6.  New enzyme lineages by subdomain shuffling.

Authors:  K P Hopfner; E Kopetzki; G B Kresse; W Bode; R Huber; R A Engh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Haemophilia B: database of point mutations and short additions and deletions, 7th edition.

Authors:  F Giannelli; P M Green; S S Sommer; M C Poon; M Ludwig; R Schwaab; P H Reitsma; M Goossens; A Yoshioka; M S Figueiredo; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

8.  Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.

Authors:  Daniel J D Johnson; Jonathan Langdown; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.

Authors:  Likui Yang; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

10.  Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.

Authors:  P O Freskgård; O H Olsen; E Persson
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.